[CITATION][C] Effect of Rosuvastatin on Hemoglobin Levels in Patients With Anemia and Low‐Grade Inflammation: A Post Hoc Analysis of the JUPITER Trial
The Journal of Clinical Pharmacology, 2011•Wiley Online Library
METHODS The data used in this study came from the Justification for the Use of Statins in
Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) study. JUPITER was a
randomized, double blind, placebo-controlled, multicenter trial that examined the effect of
treatment with 20 mg of rosuvastatin daily on risk of first major cardiovascular events in
apparently healthy persons. Patients were selected to have low-density lipoprotein (LDL)
cholesterol levels below current treatment thresholds (LDL< 130 mg/dL) but elevated levels …
Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) study. JUPITER was a
randomized, double blind, placebo-controlled, multicenter trial that examined the effect of
treatment with 20 mg of rosuvastatin daily on risk of first major cardiovascular events in
apparently healthy persons. Patients were selected to have low-density lipoprotein (LDL)
cholesterol levels below current treatment thresholds (LDL< 130 mg/dL) but elevated levels …
METHODS
The data used in this study came from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) study. JUPITER was a randomized, double blind, placebo-controlled, multicenter trial that examined the effect of treatment with 20 mg of rosuvastatin daily on risk of first major cardiovascular events in apparently healthy persons. Patients were selected to have low-density lipoprotein (LDL) cholesterol levels below current treatment thresholds (LDL< 130 mg/dL) but elevated levels of high-sensitivity CRP (hsCRP> 2 mg/L). The design of the study and main results are reported elsewhere. 16–19
Wiley Online Library